Life Sciences

  • Microbiome / Nutrition / Foodtech / Lifestyle
  • Medtech / Connected health / Digital health
  • Biotech & pharmaceuticals
  • Industrial Biotech & Cleantech
  • Animal health / Animal Feed & Nutrition

Read more

Digital Technologies

  • Fintech
  • Retailtech
  • Other digital innovative solutions
  • Hardware & telecom

Read more

Sport & Performance Capital

  • Sport-Health
  • Equipment
  • Food-Nutrition
  • IOT-Digital
  • Sports practice

Read more

Blue Economy

  • Sustainable aquacultures
  • Food, cosmetic, health & consumer products
  • Sea to ag innovative solutions
  • Recycling & remediation
  • Hydrogene & renewable energies

Read more

News

  • Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines
    5 December 2023

    Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines

    Eligo Bioscience, a pioneering gene-editing company...

  • MaaT Pharma to Present Preclinical Data at SITC on MaaT034, an Artificial Intelligence-Generated Product Aimed at Improving Patients’ Responses to Immunotherapies
    31 October 2023

    MaaT Pharma to Present Preclinical Data at SITC on MaaT034, an Artificial Intelligence-Generated Product Aimed at Improving Patients’ Responses to Immunotherapies

    MaaT Pharma (EURONEXT: MAAT – the “Company”), a...

  • Enterome Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program
    30 October 2023

    Enterome Selected to The Leukemia & Lymphoma Society’s Therapy Acceleration Program

    Enterome, a clinical-stage company developing...

  • Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.
    26 October 2023

    Pharma announces positive outcome following DSMB review reinforcing confidence in phase 3 on-going trial.

    Maat Pharma announces that the DSMB unanimoulsy...

    Read more...
  • MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013
    26 October 2023

    MaaT Pharma Announces Positive Outcome Following DSMB Review Reinforcing Confidence in Phase 3 On-Going Trial in Acute Graft-versus-Host Disease with MaaT013

    MaaT Pharma today announced that the DSMB unanimously...